EFFICACY OF PIRFENIDONE ON DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): RESULTS FROM A POST HOC RESPONDER ANALYSIS

被引：0
|
作者：
Glassberg, Marilyn K.
Thavarajah, Krishna
Collins, Bridget F.
Gupta, Sachin
Trzaskoma, Benjamin
Kirchgaessler, Klaus-Uwe
Devine, Jacob
Raghu, Ganesh
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.996
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1246A / 1247A
页数：2
相关论文
共 50 条
  • [21] HEPATIC DISORDERS OF PIRFENIDONE OR NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) A SYSTEMATIC REVIEW
    Singla, D.
    Mahapatra, S.
    Dey, A.
    John, A.
    VALUE IN HEALTH, 2022, 25 (12) : S218 - S218
  • [22] PIRFENIDONE IS EFFICACIOUS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) WITH MORE PRESERVED LUNG FUNCTION
    Noble, P. W.
    Bradford, W. Z.
    Costabel, U.
    Glaspole, I.
    Glassberg, M. K.
    Gorina, E.
    Kardatzke, D.
    Lancaster, L.
    Lederer, D. J.
    Nathan, S. D.
    Pereira, C.
    Spirig, D.
    Swigris, J. J.
    Valeyre, D.
    Albera, C.
    THORAX, 2015, 70 : A81 - A81
  • [23] Fatigue in patients with idiopathic pulmonary fibrosis (IPF) from the pooled pirfenidone (PFD) Phase III trials
    Costabel, Ulrich
    Albera, Carlo
    Wijsenbeek, Marlies S.
    de Andrade, Joao A.
    Mason, Wendi R.
    Nathan, Steven D.
    Zibrak, Joseph D.
    Padilla, Maria L.
    Gilberg, Frank
    Petzinger, Ute
    Kirchgaessler, Klaus-Uwe
    Lancaster, Lisa H.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [24] Predictors of efficacy of pirfenidone in idiopathic pulmonary fibrosis
    Kataoka, Kensuke
    Taniguchi, Hiroyuki
    Kondoh, Yasuhiro
    Kimura, Tomoki
    Matsuda, Toshiaki
    Yokoyama, Toshiki
    Yamano, Yasuhiko
    Nakahara, Yoshio
    Yagi, Mitsuaki
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [25] The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
    Valeyre, Dominique
    Albera, Carlo
    Bradford, Williamson
    Costabel, Ulrich
    King, Talmadge
    Noble, Paul
    Sahn, Steven
    du Bois, Roland
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [26] IPF Care: A Support Program for Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone in Europe
    Annette Duck
    Lucy Pigram
    Peter Errhalt
    Deeba Ahmed
    Nazia Chaudhuri
    Advances in Therapy, 2015, 32 : 87 - 107
  • [27] Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
    Takeda, Yoshito
    Tsujino, Kazuyuki
    Kijima, Takashi
    Kumanogoh, Atsushi
    PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 361 - 370
  • [28] EARLY CLINICAL EXPERIENCE WITH PIRFENIDONE FOR IDIOPATHIC PULMONARY FIBROSIS (IPF) IN THE UK: INTERIM RESULTS FROM A UK COHORT
    Parfrey, H.
    Leonard, C.
    Gibbons, M. A.
    Harris, E.
    Frank, R.
    Sharp, C.
    Dew, R. M.
    Maher, T. M.
    THORAX, 2012, 67 : A48 - A49
  • [29] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    James Patrick Finnerty
    Aravind Ponnuswamy
    Prosjenjit Dutta
    Ammar Abdelaziz
    Hafiz Kamil
    BMC Pulmonary Medicine, 21
  • [30] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    Finnerty, James Patrick
    Ponnuswamy, Aravind
    Dutta, Prosjenjit
    Abdelaziz, Ammar
    Kamil, Hafiz
    BMC PULMONARY MEDICINE, 2021, 21 (01)
12345